PPT2, or Palmitoyl-Protein Thioesterase 2, is a protein encoded by the PPT2 gene in humans. This enzyme belongs to the palmitoyl-protein thioesterase family, which are lysosomal enzymes involved in the removal of long-chain fatty acids, like palmitate, from modified cysteine residues in proteins.The process of adding a fatty acid to a protein, known as palmitoylation, is a common post-translational modification that can influence the protein's function, localization, or interaction with other proteins. By removing these fatty acids, PPT2 and other thioesterases can regulate these protein characteristics.
While the precise functions of PPT2 are still being explored, it's known to be widely expressed in many tissues, suggesting a broad role in cellular metabolism. PPT2 has been found to be especially prevalent in the brain, indicating a probable role in neuronal function.Mutations in the closely related PPT1 gene cause a severe neurodegenerative condition known as Infantile Neuronal Ceroid Lipofuscinosis (INCL), also known as Batten disease. Understanding the functions of PPT2 and its involvement in protein palmitoylation could provide important insights into cellular metabolism and protein regulation. It also represents an interesting area for potential intervention and disease research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palmitic Acid | 57-10-3 | sc-203175 sc-203175A | 25 g 100 g | $114.00 $286.00 | 2 | |
Palmitic Acid, as a substrate, may indirectly influence PPT2 activity by modulating substrate availability. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
Cerulenin inhibits fatty acid synthase, potentially influencing PPT2 activity by altering fatty acid synthesis. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin, an inhibitor of N-linked glycosylation, could affect cellular processes related to PPT2 function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to affect protein palmitoylation, potentially modulating PPT2 activity indirectly. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
Fumonisin B1 inhibits ceramide synthase, which could indirectly influence PPT2 activity through sphingolipid metabolism. | ||||||
Myriocin (ISP-1) | 35891-70-4 | sc-201397 | 10 mg | $150.00 | 8 | |
Myriocin, a potent inhibitor of serine palmitoyltransferase, might affect PPT2 activity by altering sphingolipid biosynthesis. | ||||||
4-Hydroxyphenylretinamide | 65646-68-6 | sc-200900 sc-200900A | 5 mg 25 mg | $104.00 $315.00 | ||
Fenretinide, affecting lipid metabolism and signaling, could have an indirect impact on PPT2 activity. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic Acid, a monounsaturated fatty acid, may influence lipid metabolic pathways, potentially impacting PPT2 activity. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin, a cholesterol-lowering agent, could indirectly influence PPT2 through its effects on lipid metabolism. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin, similar to Lovastatin, affects cholesterol biosynthesis and could indirectly affect PPT2 activity. | ||||||